Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein
- PMID: 26426900
- PMCID: PMC4591125
- DOI: 10.1371/journal.pone.0139370
Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein
Abstract
Green tea catechins inhibit the function of organic anion transporting polypeptides (OATPs) that mediate the uptake of a diverse group of drugs and endogenous compounds into cells. The present study was aimed at investigating the effect of green tea and its most abundant catechin epigallocatechin gallate (EGCG) on the transport activity of several drug transporters expressed in enterocytes, hepatocytes and renal proximal tubular cells such as OATPs, organic cation transporters (OCTs), multidrug and toxin extrusion proteins (MATEs), and P-glycoprotein (P-gp). Uptake of the typical substrates metformin for OCTs and MATEs and bromosulphophthalein (BSP) and atorvastatin for OATPs was measured in the absence and presence of a commercially available green tea and EGCG. Transcellular transport of digoxin, a typical substrate of P-gp, was measured over 4 hours in the absence and presence of green tea or EGCG in Caco-2 cell monolayers. OCT1-, OCT2-, MATE1- and MATE2-K-mediated metformin uptake was significantly reduced in the presence of green tea and EGCG (P < 0.05). BSP net uptake by OATP1B1 and OATP1B3 was inhibited by green tea [IC50 2.6% (v/v) and 0.39% (v/v), respectively]. Green tea also inhibited OATP1B1- and OATP1B3-mediated atorvastatin net uptake with IC50 values of 1.9% (v/v) and 1.0% (v/v), respectively. Basolateral to apical transport of digoxin was significantly decreased in the presence of green tea and EGCG. These findings indicate that green tea and EGCG inhibit multiple drug transporters in vitro. Further studies are necessary to investigate the effects of green tea on prototoypical substrates of these transporters in humans, in particular on substrates of hepatic uptake transporters (e.g. statins) as well as on P-glycoprotein substrates.
Conflict of interest statement
Figures
Similar articles
-
An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis).Planta Med. 2017 Apr;83(6):496-508. doi: 10.1055/s-0043-100934. Epub 2017 Jan 24. Planta Med. 2017. PMID: 28118673 Review.
-
The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.Mol Pharm. 2016 Feb 1;13(2):512-9. doi: 10.1021/acs.molpharmaceut.5b00733. Epub 2016 Jan 19. Mol Pharm. 2016. PMID: 26702643
-
Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.J Nat Prod. 2013 Mar 22;76(3):368-73. doi: 10.1021/np3007292. Epub 2013 Jan 17. J Nat Prod. 2013. PMID: 23327877 Free PMC article.
-
Inhibition of hepatic uptake transporters by flavonoids.Eur J Pharm Sci. 2012 May 12;46(1-2):79-85. doi: 10.1016/j.ejps.2012.02.014. Epub 2012 Feb 28. Eur J Pharm Sci. 2012. PMID: 22394605
-
In vitro evidence for the role of OATP and OCT uptake transporters in drug-drug interactions.Expert Opin Drug Metab Toxicol. 2009 May;5(5):489-500. doi: 10.1517/17425250902911463. Expert Opin Drug Metab Toxicol. 2009. PMID: 19416085 Review.
Cited by
-
Possible Side Effects of Polyphenols and Their Interactions with Medicines.Molecules. 2023 Mar 10;28(6):2536. doi: 10.3390/molecules28062536. Molecules. 2023. PMID: 36985507 Free PMC article. Review.
-
Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database.Sci Rep. 2022 Aug 19;12(1):14178. doi: 10.1038/s41598-022-17704-z. Sci Rep. 2022. PMID: 35986023 Free PMC article.
-
The Influence of EGCG on the Pharmacokinetics and Pharmacodynamics of Bisoprolol and a New Method for Simultaneous Determination of EGCG and Bisoprolol in Rat Plasma.Front Nutr. 2022 May 31;9:907986. doi: 10.3389/fnut.2022.907986. eCollection 2022. Front Nutr. 2022. PMID: 35711541 Free PMC article.
-
Herb-Drug Interaction in Inflammatory Diseases: Review of Phytomedicine and Herbal Supplements.J Clin Med. 2022 Mar 12;11(6):1567. doi: 10.3390/jcm11061567. J Clin Med. 2022. PMID: 35329893 Free PMC article. Review.
-
Mechanistic Basis for the Role of Phytochemicals in Inflammation-Associated Chronic Diseases.Molecules. 2022 Jan 25;27(3):781. doi: 10.3390/molecules27030781. Molecules. 2022. PMID: 35164043 Free PMC article. Review.
References
-
- Fujita K. Food-drug interactions via human cytochrome P450 3A (CYP3A). Drug Metabol Drug Interact. 2004;20(4):195–217. Epub 2011/5/11. . - PubMed
-
- Schmidt LE, Dalhoff K. Food-drug interactions. Drugs. 2002;62(10):1481–502. Epub 2002/7. . - PubMed
-
- Yang CS, Landau JM. Effects of tea consumption on nutrition and health. J Nutr. 2000;130(10):2409–12. Epub 2000/10/1. . - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous